A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

Cedar Associates LLC

Status: Terminated

Conditions: Neoplasm Metastasis

Treatments: Device: Pathwork® Tissue of Origin Test

Study type: Observational

Funder types: Other

Identifiers

NCT01649453

10043P

Details and patient eligibility

About

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Enrollment: 19 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013
• the patient is ≥ 18 years of age
• the patient has given informed consent (online or verbal)
• the patient is able to understand English.

Trial design

19 participants in 1 patient group

Cancer of uncertain primary

Treatment:

Device: Pathwork® Tissue of Origin Test